Company news
IN8bio, Inc. news in 2026
IN8bio, Inc.'s news releases, calls and decks from 2026, newest first.
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 6, 2026
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
September 9, 2026
IN8bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
August 11, 2026
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 6, 2026
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
July 9, 2026
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
June 3, 2026
IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
June 1, 2026
IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
May 14, 2026
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
May 6, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 2, 2026
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
March 12, 2026
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
February 24, 2026
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
February 9, 2026
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
February 3, 2026
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
January 12, 2026